A class action lawsuit has been filed against Portillo's Inc., alleging the company and its executives misled investors about the success of its rapid expansion. The lawsuit claims Portillo's overbuilt stores in unknown markets, cannibalized its own sales, and failed to generate enough customer interest, leading to poor financial performance. The company reportedly had to offer promotions that hurt same-store sales and eventually cut its 2025 revenue and earnings guidance, causing a significant stock price drop. Investors who bought shares between September 2023 and May 2026 are encouraged to contact the law firm before the January 2027 deadline to participate in the lawsuit.
The class action lawsuit against Portillo's Inc. provides context for consumer cyclical sector activity on Pluang. As of Nov 13, 2026 00:41 WIB, 33 of 134 consumer cyclical stocks rose while 101 fell. Notable movers include Stellantis N.V. at USD 3.92 with a 4.50% decline, ON Holding AG at USD 33.28 down 4.12% with 90% sell order activity, and Rivian Automotive at USD 13.03, which saw a 3.77% drop but 100% buy order activity.
D.A. Davidson raised Riskified's price target to $12, reflecting a 22.2% potential upside from $9.82. The company reported a 41% revenue increase to $115.2 million and adjusted earnings of $0.07 per share, beating estimates. Profitability improved wi...
TRM Labs introduced the Disruption Awards to recognize coalitions of public and private organizations that successfully disrupted major cybercrimes in 2026. Winners include groups that took down a phishing service responsible for most Microsoft-block...
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
